Evidence map›Paper›PMID 27966456›Full record

ArticleOncotarget2017

Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.

Sara Lázaro, Miriam Pérez-Crespo, Ana Belén Enguita, Pilar Hernández, Jesús Martínez-Palacio, Marta Oteo, Julien Sage, Jesús M Paramio, Mirentxu Santos

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Monitoring the Cell Cycle of Tumor Cells in Mouse Models of Human Cancer.Cold Spring Harbor perspectives in medicine · 2023
    Article
  4. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  10. Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sara LázaroMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Miriam Pérez-CrespoMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Ana Belén EnguitaPathology Department, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Pilar HernándezMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Jesús Martínez-PalacioMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Marta OteoBiomedical Applications and Pharmacokinetics CIEMAT (ed 70A), Madrid, Spain.
Julien SageDepartment of Pediatrics, Stanford University, Stanford, USA.
Jesús M ParamioMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Mirentxu SantosMolecular Oncology Unit, Institute of Biomedical Investigation University Hospital "12 de Octubre", Madrid, Spain.
Research Institute Hospital 12 de Octubre · ESCentro de Investigación Biomédica en Red de Cáncer · ESCentro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESStanford University · US

Funding

The RB pathway in liver cancerR01CA114102 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2006 to 2016
$2.9M
NCI NIH HHS R01 CA114102
6 · The paper itself

Abstract

Lung cancer is a deadly disease with increasing cases diagnosed worldwide and still a very poor prognosis. While mutations in the retinoblastoma (RB1) tumor suppressor have been reported in lung cancer, mainly in small cell lung carcinoma, the tumor suppressive role of its relatives p107 and p130 is still a matter of debate. To begin to investigate the role of these two Rb family proteins in lung tumorigenesis, we have generated a conditional triple knockout mouse model (TKO) in which the three Rb family members can be inactivated in adult mice. We found that ablation of all three family members in the lung of mice induces tumorlets, benign neuroendocrine tumors that are remarkably similar to their human counterparts. Upon chemical carcinogenesis, DHPN and urethane accelerate tumor development; the TKO model displays increased sensitivity to DHPN, and urethane increases malignancy of tumors. All the tumors developing in TKO mice (spontaneous and chemically induced) have neuroendocrine features but do not progress to fully malignant tumors. Thus, loss of Rb and its family members confers partial tumor susceptibility in neuroendocrine lineages in the lungs of mice. Our data also imply the requirement of other oncogenic signaling pathways to achieve full transformation in neuroendocrine lung lesions mutant for the Rb family.

Indexed as

AnimalsCell Transformation, NeoplasticLung NeoplasmsMiceMice, KnockoutNeoplasms, ExperimentalNeuroendocrine TumorsNitrosaminesRetinoblastoma-Like Protein p107Retinoblastoma-Like Protein p130Retinoblastoma ProteinSignal TransductionUrethanediisopropanolnitrosamineNitrosaminesRbl1 protein, mouseRbl2 protein, mouseRetinoblastoma-Like Protein p107Retinoblastoma-Like Protein p130Retinoblastoma ProteinUrethaneDHPNlung cancerretinoblastoma familyurethane

Identifiers

PMID27966456
PMCPMC5354839
OpenAlexW2560179853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.